Analyst Moves: PFE, KR, SODA

7 views
  • About
  • Add to
This morning, Jefferies downgraded shares of Pfizer (PFE) from buy to hold citing valuation. The stock is approaching the firm's $30 price target, reducing the risk/reward profile.

0 comments